Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Impact Biomedical Inc. (IBO) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Impact Biomedical Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1834105.
Total stock buying since 2024: $161,032.
Total stock sales since 2024: $7,286,593.
Total stock option exercises since 2024: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 200 | $310 | 6,117,866 | $7,286,535 | 0 | $0 |
| 2024 | 60,850 | $160,722 | 20 | $58 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-04 | 0 | $0 | 5,158,966 | $4,777,639 | 0 | $0 |
| 2025-03 | 200 | $310 | 958,900 | $2,508,896 | 0 | $0 |
| 2024-12 | 500 | $1,129 | 20 | $58 | 0 | $0 |
| 2024-11 | 1,550 | $4,043 | 0 | $0 | 0 | $0 |
| 2024-09 | 58,800 | $155,550 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-04 | Alset Inc. | Sale | 180,000 | .96 | 172,800 |
| 2025-04-04 | Dss, Inc. | Sale | 890,800 | .95 | 845,369 |
| 2025-04-03 | Alset Inc. | Sale | 624,917 | .68 | 424,318 |
| 2025-04-03 | Chan Heng Fai Ambrose | Sale | 351,555 | .49 | 174,019 |
| 2025-04-02 | Alset Inc. | Sale | 884,776 | .63 | 555,639 |
| 2025-04-01 | Alset Inc. | Sale | 2,226,918 | 1.17 | 2,605,494 |
| 2025-03-31 | Alset Inc. | Sale | 300,000 | 1.03 | 308,400 |
| 2025-03-27 | Dss, Inc. | Sale | 47,681 | 2.50 | 119,250 |
| 2025-03-26 | Dss, Inc. | Sale | 58,139 | 3.14 | 182,556 |
| 2025-03-21 | Dss, Inc. | Sale | 499,800 | 3.30 | 1,649,340 |
| 2025-03-20 | Dss, Inc. | Buy | 200 | 1.55 | 310 |
| 2025-03-20 | Dss, Inc. | Sale | 53,280 | 4.68 | 249,350 |
| 2024-12-05 | Heuszel Frank D (Chief Executive Officer) | Buy | 500 | 2.26 | 1,129 |
| 2024-12-02 | Dss, Inc. | Sale | 20 | 2.90 | 58 |
| 2024-11-27 | Heuszel Frank D (Chief Executive Officer) | Buy | 500 | 2.61 | 1,305 |
| 2024-11-26 | Heuszel Frank D (Chief Executive Officer) | Buy | 1,050 | 2.61 | 2,738 |
| 2024-09-18 | Dss, Inc. | Buy | 1,000 | 2.33 | 2,330 |
| 2024-09-17 | Dss, Inc. | Buy | 7,800 | 2.40 | 18,720 |
| 2024-09-16 | Dss, Inc. | Buy | 50,000 | 2.69 | 134,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of IBO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Impact Biomedical Inc. (symbol IBO, CIK number 1834105) see the Securities and Exchange Commission (SEC) website.